<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04586218</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A03191-56</org_study_id>
    <nct_id>NCT04586218</nct_id>
  </id_info>
  <brief_title>Controling Mean Arterial Pressure Using a Closed-Loop System for Vasopressor Titration</brief_title>
  <acronym>COMAP</acronym>
  <official_title>Postoperative Hypotension Management With Computer-guided Vasopressor Titration in High-Risk Patients After Cardiac Surgery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinique de la Sauvegarde</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bicetre Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinique de la Sauvegarde</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators have developed an automated vasopressor controller to improve the titration&#xD;
      of vasopressor in order to maintain mean arterial pressure (MAP) within a narrow range and&#xD;
      have recently shown the controller was effective in both the operating room and intensive&#xD;
      care unit. The controller has been used recently in a case series of three patients&#xD;
      undergoing cardiac surgery and in five patients after cardiac surgery.&#xD;
&#xD;
      The investigators want to compare now a manual to a closed-loop titration of vasopressor&#xD;
      infusion in patients admitted in the Intensive Care unit after cardiac surgery&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Perioperative hypotension and arterial pressure variability have been shown to negatively&#xD;
      impact patient outcomes, increasing risk of stroke, kidney injury, and myocardial injury&#xD;
      among others.&#xD;
&#xD;
      Vasopressors are usually used to rapidly correct hypotension. Vasopressor infusions are&#xD;
      typically administered by standard infusion pump with the rate adjusted by anesthesiologists&#xD;
      to reach a predefined target mean arterial pressure (MAP); this requires frequent changes in&#xD;
      the infusion rate because of the almost constantly changing hemodynamic status of such&#xD;
      patients. Because it is infeasible for human providers to pay constant attention and make&#xD;
      second-to-second changes, management is often suboptimal (i.e. large amounts of time are&#xD;
      spent in hypotension below the target, or well above the target with the vasopressor drip&#xD;
      still running).&#xD;
&#xD;
      The investigators have developed an automated closed-loop vasopressor (CLV) controller to&#xD;
      improve the titration of vasopressor (e.g:noradrenaline) in order to maintain MAP within a&#xD;
      narrow range in the perioperative setting. The investigators have published engineering,&#xD;
      animal and most recently, pilot,studies or case series with promising results.&#xD;
&#xD;
      In this randomized controlled trial, the investigators will compare time spent in hypotension&#xD;
      defined as a mean arterial pressure &lt; 65 mmHg. They tested the hypothesis that the automated&#xD;
      system will allow patients to spent less time during the postoperative period with a MAP &lt; 65&#xD;
      mmHg. This is thus a superiority study over a two hours study period&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 26, 2020</start_date>
  <completion_date type="Actual">December 17, 2020</completion_date>
  <primary_completion_date type="Actual">December 17, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled superiority trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of postoperative hypotension</measure>
    <time_frame>postoperative hour 2</time_frame>
    <description>Percentage of treatment period spent with a MAP &lt; 65 mmHg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of vasopressor infusion rate modifications</measure>
    <time_frame>postoperative hour 2</time_frame>
    <description>Number of vasopressor infusion rate modifications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of vasopressor</measure>
    <time_frame>postoperative hour 2</time_frame>
    <description>Amount of noradrenaline received during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>amount of fluid</measure>
    <time_frame>postoperative hour 2</time_frame>
    <description>amount of fluid received during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of acute kidney injury</measure>
    <time_frame>postoperative day 7</time_frame>
    <description>incidence of acute kidney injury at postoperative day 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>troponin values</measure>
    <time_frame>postoperative day 0</time_frame>
    <description>troponin values at intensive care arrival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>troponin values</measure>
    <time_frame>postoperative day 1</time_frame>
    <description>troponin values at postoperative day 1</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Manual control of vasopressor infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vasopressor will be manually titrated by intensive care unit nurses in charge of the patients to maintain mean arterial pressure &gt; 65 mmHg.&#xD;
Fluid administration consists in optimization of stroke volume (assisted fluid management) during the postoperative period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Computer guided vasopressor infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vasopressor will be titrated automatically by the closed-loop system to maintain mean arterial pressure &gt; 65 mmHg.&#xD;
Fluid administration consists in optimization of stroke volume (assisted fluid management) during the postoperative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Computer guided vasopressor infusion</intervention_name>
    <description>automated titration of vasopressor infusion to maintain a mean arterial pressure &gt; 65mmHg</description>
    <arm_group_label>Computer guided vasopressor infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Manual control of vasopressor infusion</intervention_name>
    <description>manual adjustments of noradrenaline infusion</description>
    <arm_group_label>Manual control of vasopressor infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient&#xD;
&#xD;
          -  Elective cardiac surgery&#xD;
&#xD;
          -  French speaking patient&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Renal insufficiency (estimated glomerular filtration rate &lt; 30mL/min/1,73mÂ²)&#xD;
&#xD;
          -  Left ejection fraction &lt; 40%&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  Preoperative infection&#xD;
&#xD;
          -  Preoperative cardiac arrythmia&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Desebbe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique de la Sauvegarde</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinique de la Sauvegarde</name>
      <address>
        <city>Lyon</city>
        <zip>69009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>December 19, 2020</last_update_submitted>
  <last_update_submitted_qc>December 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

